semaglutide company stock Novo Nordisk Tumbles as Wegovy Copycats Weigh on Results Novo Nordisk shares slide after

## The Oral GLP-1 Landscape in 2026 The treatment of obesity is entering a new phase defined by oral medications

Oxidative Medicine and Cellular Longevity, 2021 (1), 2074610

Many studies have shown that children who receive intensive early intervention servicesespecially those who receive at least two years of intensive intervention prior to entering elementary schoolexperience significant gains in functional communication, cognitive skills, and behavior and need fewer support services in school

Clinical data shows most patients begin experiencing appetite return within 37 days of their final GLP-1 injection, though the timeline varies by individual metabolism

10.1530/eje.0.1340362 54